Filing Details
- Accession Number:
- 0001209191-13-007003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-07 12:50:09
- Reporting Period:
- 2013-01-31
- Filing Date:
- 2013-02-07
- Accepted Time:
- 2013-02-07 12:50:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293310 | Kalobios Pharmaceuticals Inc | KBIO | Pharmaceutical Preparations (2834) | 770557236 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1121404 | Sanofi | 54, Rue La Bo?Tie Paris I0 75008 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-31 | 87,500 | $8.00 | 579,030 | No | 4 | P | Indirect | by wholly-owned subsidiary Genzyme Corp. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | by wholly-owned subsidiary Genzyme Corp. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Preferred Shares | Disposition | 2013-02-05 | 431,973 | $0.00 | 491,530 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- Initially one-for-one. Following a reverse merger and an anti dilution conversion on January 15, 2013 the original 1 538 461 Preferred Stocks where converted into 491 530 Common Stock.
- Initially 1 538 461 ultimately 431 973 following a reverse merger.
- Exercisable at any time
- Not applicable
- Not applicable
Billionaire Hedge Funds
